Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,234 | $0.04 | $409.36 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 5 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,153 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · derivative · entry 8 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,935 Underlying: Common Stock · 9,153 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 9,153 | $5.07 | $46,405.71 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 9,153 | $0.98 | $8,997.40 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,153 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · derivative · entry 8 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,314 Underlying: Common Stock · 9,153 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 9,153 | $5.07 | $46,405.71 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 4 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 9,153 | $0.04 | $366.12 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 3 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,513 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · derivative · entry 7 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,088 Underlying: Common Stock · 10,513 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 10,513 | $5.13 | $53,931.69 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 10,513 | $0.98 | $10,334.28 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,613 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · derivative · entry 7 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,467 Underlying: Common Stock · 10,613 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 10,613 | $5.13 | $54,444.69 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 2 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,613 | $0.04 | $424.52 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,133 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,601 Underlying: Common Stock · 14,133 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 14,133 | $5.59 | $79,003.47 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.35 to $5.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 14,133 | $1.08 | $15,263.64 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · derivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,734 Underlying: Common Stock · 15,000 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 15,000 | $6.02 | $90,300.00 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.00 to $6.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 15,000 | $1.08 | $16,200.00 |
DisclosureSEC source: 0001209191-22-060077 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 21:43 UTC |
BALTHROP PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $5.99 | $0.00 |
DisclosureSEC source: 0001209191-22-059200 · doc4.xml · derivative · entry 1 BALTHROP PATRICK J · CIK 0001284839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-29 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 1/3rd of the shares underlying this option vest on November 30, 2023 and the remaining 2/3rds vest in 24 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,266 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · derivative · entry 8 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,734 Underlying: Common Stock · 1,266 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,438 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · derivative · entry 7 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,438 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 5,704 | $6.85 | $39,072.40 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · nonDerivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.72 to $6.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 1,266 | $1.08 | $1,367.28 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 4,438 | $0.84 | $3,727.92 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,429 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438 Underlying: Common Stock · 23,429 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 23,429 | $6.94 | $162,597.26 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.80 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:53 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 23,429 | $0.84 | $19,680.36 |
DisclosureSEC source: 0001209191-22-055528 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| October 11, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,282 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,867 Underlying: Common Stock · 4,282 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 11, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 4,282 | $6.51 | $27,875.82 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.40 to $6.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 11, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 4,282 | $0.84 | $3,596.88 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,851 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · derivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,149 Underlying: Common Stock · 24,851 shares Expires 2026-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 24,851 | $6.45 | $160,288.95 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.31 to $6.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:09 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 24,851 | $0.84 | $20,874.84 |
DisclosureSEC source: 0001209191-22-053456 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:24 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
SaleCommon Stock, par value $0.01 per share | 735,786 | $6.15 | $4,525,083.90 |
DisclosureSEC source: 0000919574-22-005788 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000,000 F1 · ownership.direct: (1) The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:01 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
SaleCommon Stock, par value $0.01 per share | 3,235,548 | $4.30 | $13,912,856.40 |
DisclosureSEC source: 0000919574-22-004059 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,735,786 F1 · ownership.direct: The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:05 UTC |
DOUGLAS RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041612 · doc4.xml · derivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:02 UTC |
Johnston John JosephDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041606 · doc4.xml · derivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 16:02 UTC |
Mandell ArtDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041605 · doc4.xml · derivative · entry 1 Mandell Art · CIK 0001874506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:04 UTC |
Erck Stanley CDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041608 · doc4.xml · derivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:06 UTC |
Al-Wakeel Yasir B.Director
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041614 · doc4.xml · derivative · entry 1 Al-Wakeel Yasir B. · CIK 0001650691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:04 UTC |
Brooke William WDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041609 · doc4.xml · derivative · entry 1 Brooke William W · CIK 0001545337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 29, 2022 Filed Jul 8, 2022 20:03 UTC |
Hemrajani RekhaDirector
|
GrantStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001209191-22-041607 · doc4.xml · derivative · entry 1 Hemrajani Rekha · CIK 0001771213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2032-06-28 F1 · derivative.exercise_date: This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| April 11, 2022 Filed Mar 21, 2023 20:41 UTC |
Sumen CenkChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $5.70 | $0.00 |
DisclosureSEC source: 0001209191-23-020283 · doc4.xml · derivative · entry 1 Sumen Cenk · CIK 0001917133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2032-04-10 F1 · date: As announced in a press release by the issuer on April 15, 2022, on April 11, 2022 the Issuer awarded a stock option to the Reporting Person as a material inducement to his employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option was granted under the Issuer's 2021 Inducement Plan. However, due to an administrative oversight, the stock option grant was not previously reported on a Form 4 as required and is being reported on this report. F2 · derivative.exercise_date: 25% of the shares underlying this option vest on April 11, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:15 UTC |
Doerfler DouglasDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021460 · doc4.xml · derivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:16 UTC |
Murphy Amanda LouiseChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 142,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021464 · doc4.xml · derivative · entry 1 Murphy Amanda Louise · CIK 0001875169 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Underlying: Common Stock · 142,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:20 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
GrantEmployee Stock Option (right to buy) · Derivative | 142,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021474 · doc4.xml · derivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Underlying: Common Stock · 142,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:21 UTC |
Masoud MaherEVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 242,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021481 · doc4.xml · derivative · entry 1 Masoud Maher · CIK 0001874571 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,000 Underlying: Common Stock · 242,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 16:18 UTC |
Holtz RonSVP and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 142,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-22-021470 · doc4.xml · derivative · entry 1 Holtz Ron · CIK 0001874490 · SVP and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Underlying: Common Stock · 142,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 12:46 UTC |
DOUGLAS RICHARDDirector
|
PurchaseCommon Stock | 20,000 | $11.12 | $222,400.00 |
DisclosureSEC source: 0001209191-21-066289 · doc4.xml · nonDerivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $11.01 to $11.16 per share, with a weighted average purchase price of $11.12 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.